person · Reporting owner

EISENBERG GLENN A

Disclosed activity across 10 companies

Tapewire entity: 18882
SEC CIK: 0001222831

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Fortrea Holdings Inc.FTRE · Entity 4623	Director · Executive Vice President	June 20, 2023	June 21, 2023
LABCORP HOLDINGS INC.LH · Entity 1277	Executive Vice President	March 27, 2025	March 31, 2025
Lumexa Imaging Holdings, Inc.LMRI · Entity 4888	Director	June 10, 2026	June 12, 2026
MIDDLEBY CorpMIDD · Entity 3889	Director	July 20, 2026	August 28, 2026
MiniMed Group, Inc.MMED · Entity 3758	Director	October 09, 2026	October 13, 2026
SEQUENOM INCSQNM · Entity 182543	Director · EVP and Treasurer	September 07, 2016	September 07, 2016
Solventum CorpSOLV · Entity 1645	Director	May 15, 2026	May 18, 2026
US Ecology, Inc.ECOL · Entity 127674	Director	May 02, 2022	May 03, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Fortrea Holdings Inc.

Report date June 20, 2023 · Filed June 21, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	42,176	Reported balance After 2023-06-20 transaction · row 1 1 source row Row 1 · 2023-06-20 · Other · Acquired 42,176 · Balance 42,176 F1: In connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), Labcorp will distribute all of the outstanding shares of Fortrea common stock held by Labcorp to Labcorp common stockholders as of the record date, which was the close of business on June 20, 2023 (the "Record Date"). For each share of Labcorp common stock held on the Record Date, Labcorp will distribute one share of Fortrea common stock.

Filing footnotes · ownership attribution and instrument terms

F1: In connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), Labcorp will distribute all of the outstanding shares of Fortrea common stock held by Labcorp to Labcorp common stockholders as of the record date, which was the close of business on June 20, 2023 (the "Record Date"). For each share of Labcorp common stock held on the Record Date, Labcorp will distribute one share of Fortrea common stock.

LABCORP HOLDINGS INC.

Report date March 27, 2025 · Filed March 31, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	37,920	Ending reported balance After 2025-03-27 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2025-03-27 · Grant · Acquired 8,305 · Balance 41,550 F1: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024. Row 2 · 2025-03-27 · Tax withholding · Disposed 3,630 · Balance 37,920 F2: Stock withholding to satisfy tax withholding obligations.

Filing footnotes · ownership attribution and instrument terms

F1: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024.

F2: Stock withholding to satisfy tax withholding obligations.

Lumexa Imaging Holdings, Inc.

Report date June 10, 2026 · Filed June 12, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	19,358	Reported balance After 2026-06-10 transaction · row 1 1 source row Row 1 · 2026-06-10 · Grant · Acquired 19,358 · Balance 19,358 F1: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.

MIDDLEBY Corp

Report date July 20, 2026 · Filed August 28, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,510	Reported balance After 2026-07-20 transaction · row 1 1 source row Row 1 · 2026-07-20 · Conversion · Acquired 349 · Balance 1,510 F1: Represents the conversion of 1,161 RSUs into 1,510 RSUs pursuant to the adjustment required by the Employee Matters Agreement entered into in connection with the spin-off of Midera Food Processing, Inc. from Middleby, which was completed on July 6, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the conversion of 1,161 RSUs into 1,510 RSUs pursuant to the adjustment required by the Employee Matters Agreement entered into in connection with the spin-off of Midera Food Processing, Inc. from Middleby, which was completed on July 6, 2026.

MiniMed Group, Inc.

Report date October 09, 2026 · Filed October 13, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	25,684	Reported balance After 2026-10-09 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-10-09 · Grant · Acquired 11,795 · Balance 25,684 F1: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date. F2: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date.

F2: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.

SEQUENOM INC

Report date September 07, 2016 · Filed September 07, 2016

This filing explicitly reported no securities owned.

Solventum Corp

Report date May 15, 2026 · Filed May 18, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	3,300	Reported balance After 2026-05-15 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-05-15 · Grant · Acquired 3,300 · Balance 3,300 F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2: The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

F2: The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date.

US Ecology, Inc.

Report date May 02, 2022 · Filed May 03, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2022-05-02 transaction · row 1 1 source row Row 1 · 2022-05-02 · Disposition to issuer · Disposed 9,000 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. ("Parent") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest ("Merger Consideration").

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. ("Parent") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest ("Merger Consideration").

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Perspecta Inc.

Report date May 06, 2021 · Filed May 06, 2021

Section 16 reporting ended · disclosed 2021-05-06. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2021-05-06 transaction · row 1 1 source row Row 1 · 2021-05-06 · Disposition to issuer · Disposed 14,400 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among Perspecta Inc. (the "Company"), Jaguar ParentCo Inc. ("Parent") and Jaguar Merger Sub Inc. ("Merger Sub"), on May 6, 2021, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.01 per share, of the Company (each, a "Share") was canceled and converted into the right to receive $29.35 in cash without interest and less any applicable tax withholdings.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among Perspecta Inc. (the "Company"), Jaguar ParentCo Inc. ("Parent") and Jaguar Merger Sub Inc. ("Merger Sub"), on May 6, 2021, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.01 per share, of the Company (each, a "Share") was canceled and converted into the right to receive $29.35 in cash without interest and less any applicable tax withholdings.

US Ecology Holdings, Inc.

Report date November 01, 2019 · Filed November 01, 2019

Section 16 reporting ended · disclosed 2019-11-01. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2019-11-01 transaction · row 1 1 source row Row 1 · 2019-11-01 · Disposition to issuer · Disposed 3,000 · Balance 0 F1: Disposed pursuant to that certain Agreement and Plan of Merger, dated as of June 23, 2019, by and among US Ecology Holdings, Inc. (f/k/a US Ecology, Inc.) ("Parent"), NRC Group Holdings Corp., US Ecology, Inc. (f/k/a US Ecology Parent, Inc.) ("Holdco"), ECOL Merger Sub, Inc. ("ECOL Merger Sub") and Rooster Merger Sub, Inc., in a merger transaction in which ECOL Merger Sub merged with and into Parent, and each issued and outstanding share of Parent's common stock was converted into the right to receive, and became exchangeable for, one share of common stock, par value $0.01 of Holdco.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed pursuant to that certain Agreement and Plan of Merger, dated as of June 23, 2019, by and among US Ecology Holdings, Inc. (f/k/a US Ecology, Inc.) ("Parent"), NRC Group Holdings Corp., US Ecology, Inc. (f/k/a US Ecology Parent, Inc.) ("Holdco"), ECOL Merger Sub, Inc. ("ECOL Merger Sub") and Rooster Merger Sub, Inc., in a merger transaction in which ECOL Merger Sub merged with and into Parent, and each issued and outstanding share of Parent's common stock was converted into the right to receive, and became exchangeable for, one share of common stock, par value $0.01 of Holdco.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 11, 2024 Filed Feb 13, 2024 17:16 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionRestricted Stock Unit · Derivative	807	$0.00	$0.00	Disclosure SEC source: 0001127602-24-004642 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,739 Underlying: Common Stock · 807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
February 11, 2024 Filed Feb 13, 2024 17:16 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	807	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-24-004642 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document
February 07, 2024 Filed Feb 8, 2024 20:26 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionRestricted Stock Unit · Derivative	885	$0.00	$0.00	Disclosure SEC source: 0001127602-24-003960 · form4.xml · derivative · entry 5 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,546 Underlying: Common Stock · 885 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F7 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
February 07, 2024 Filed Feb 8, 2024 20:26 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	236	$223.71	$52,795.56	Disclosure SEC source: 0001127602-24-003960 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,453 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
February 07, 2024 Filed Feb 8, 2024 20:26 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	885	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-24-003960 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document
February 06, 2024 Filed Feb 8, 2024 20:26 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	GrantNon-qualified Stock Options · Derivative	9,000	$0.00 Strike: $222.28	$0.00	Disclosure SEC source: 0001127602-24-003960 · form4.xml · derivative · entry 4 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2034-02-05 F5 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F6 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document
February 06, 2024 Filed Feb 8, 2024 20:26 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	GrantRestricted Stock Unit · Derivative	2,900	$0.00	$0.00	Disclosure SEC source: 0001127602-24-003960 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,431 Underlying: Common Stock · 2,900 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
February 02, 2024 Filed Feb 6, 2024 20:55 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionRestricted Stock Unit · Derivative	856	$0.00	$0.00	Disclosure SEC source: 0001127602-24-003546 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,531 Underlying: Common Stock · 856 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 2, 2022 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 2, 2022 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 1,430 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc. Read SEC document
February 02, 2024 Filed Feb 6, 2024 20:55 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	228	$221.54	$50,511.12	Disclosure SEC source: 0001127602-24-003546 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,804 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
February 02, 2024 Filed Feb 6, 2024 20:55 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	856	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-24-003546 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document
June 30, 2023 Filed Jul 6, 2023 00:02 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	GrantRestricted Stock Unit · Derivative	20,193	$0.00	$0.00	Disclosure SEC source: 0001127602-23-020294 · form4.xml · derivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,957 Underlying: Common Stock · 20,193 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: In connection with the spin-off ("Spin-Off") of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the "2021 PSA") were converted into time-vesting restricted stock units ("RSUs") of Labcorp pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea (the "EMA"). The 2021 PSA was converted into a number of time-vesting Labcorp RSUs based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the adjustment ratio that applies to Labcorp equity awards in the Spin-Off, with vesting on the 30th day following Labcorp's filing of an annual report on Form 10-K that includes audited financial statements with respect to the 3-year period ending December 31, 2023. Amounts are estimates pending finalization of the adjustment ratio pursuant to the EMA. F2 · derivative.expiration_date: In connection with the spin-off ("Spin-Off") of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the "2021 PSA") were converted into time-vesting restricted stock units ("RSUs") of Labcorp pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea (the "EMA"). The 2021 PSA was converted into a number of time-vesting Labcorp RSUs based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the adjustment ratio that applies to Labcorp equity awards in the Spin-Off, with vesting on the 30th day following Labcorp's filing of an annual report on Form 10-K that includes audited financial statements with respect to the 3-year period ending December 31, 2023. Amounts are estimates pending finalization of the adjustment ratio pursuant to the EMA. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
June 20, 2023 Filed Jun 21, 2023 17:53 UTC	Fortrea Holdings Inc. FTRE · Entity 4623	OtherCommon Stock	42,176	$0.00	$0.00	Disclosure SEC source: 0001127602-23-019190 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,176 F1 · kind: In connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), Labcorp will distribute all of the outstanding shares of Fortrea common stock held by Labcorp to Labcorp common stockholders as of the record date, which was the close of business on June 20, 2023 (the "Record Date"). For each share of Labcorp common stock held on the Record Date, Labcorp will distribute one share of Fortrea common stock. Read SEC document
March 30, 2023 Filed Apr 3, 2023 14:11 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	5,179	$224.70	$1,163,721.30	Disclosure SEC source: 0001127602-23-011749 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,176 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
March 30, 2023 Filed Apr 3, 2023 14:11 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	GrantCommon Stock	11,715	$0.00	$0.00	Disclosure SEC source: 0001127602-23-011749 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,355 F1 · kind: Shares acquired on March 30, 2023, pursuant to a performance award granted on February 4, 2020, relating to performance during the three-year period ended December 31, 2022. Read SEC document
February 13, 2023 Filed Feb 14, 2023 19:56 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	195	$248.13	$48,385.35	Disclosure SEC source: 0001127602-23-005102 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,640 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
February 11, 2023 Filed Feb 14, 2023 19:56 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionRestricted Stock Unit · Derivative	723	$0.00	$0.00	Disclosure SEC source: 0001127602-23-005102 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,764 Underlying: Common Stock · 723 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
February 11, 2023 Filed Feb 14, 2023 19:56 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	723	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-23-005102 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document
February 07, 2023 Filed Feb 9, 2023 14:28 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	GrantNon-qualified Stock Options · Derivative	7,500	$0.00 Strike: $247.24	$0.00	Disclosure SEC source: 0001127602-23-004100 · form4.xml · derivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2033-02-06 F4 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F5 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document
February 07, 2023 Filed Feb 9, 2023 14:28 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	GrantRestricted Stock Unit · Derivative	2,380	$0.00	$0.00	Disclosure SEC source: 0001127602-23-004100 · form4.xml · derivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,487 Underlying: Common Stock · 2,380 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024. F2 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
February 06, 2023 Filed Feb 7, 2023 19:52 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	261	$244.50	$63,814.50	Disclosure SEC source: 0001127602-23-003704 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,112 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
February 04, 2023 Filed Feb 7, 2023 19:52 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionRestricted Stock Unit · Derivative	970	$0.00	$0.00	Disclosure SEC source: 0001127602-23-003704 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,107 Underlying: Common Stock · 970 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
February 04, 2023 Filed Feb 7, 2023 19:52 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	970	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-23-003704 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document
February 02, 2023 Filed Feb 6, 2023 20:43 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionRestricted Stock Unit · Derivative	767	$0.00	$0.00	Disclosure SEC source: 0001127602-23-003530 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,077 Underlying: Common Stock · 767 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
February 02, 2023 Filed Feb 6, 2023 20:43 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	206	$254.99	$52,527.94	Disclosure SEC source: 0001127602-23-003530 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,403 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
February 02, 2023 Filed Feb 6, 2023 20:43 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	767	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-23-003530 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:04 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionRestricted Stock Unit · Derivative	12,032	$0.00	$0.00	Disclosure SEC source: 0001127602-22-024923 · form4.xml · derivative · entry 5 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,844 Underlying: Common Stock · 12,032 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vested in three installments as follows: 30% of the Restricted Stock Units vested on November 1, 2020; 30% of the Restricted Stock Units vested on November 1, 2021; and 40% of the Restricted Stock Units vested on November 1, 2022, with the third installment subject to a relative total shareholder return ("TSR") modifier that could have adjusted the third installment of the Restricted Stock Units upward or downward 25% based on our three-year cumulative relative TSR but ultimately did not result in an adjustment. F7 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vested in three installments as follows: 30% of the Restricted Stock Units vested on November 1, 2020; 30% of the Restricted Stock Units vested on November 1, 2021; and 40% of the Restricted Stock Units vested on November 1, 2022, with the third installment subject to a relative total shareholder return ("TSR") modifier that could have adjusted the third installment of the Restricted Stock Units upward or downward 25% based on our three-year cumulative relative TSR but ultimately did not result in an adjustment. F8 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:04 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	GrantRestricted Stock Unit · Derivative	9,170	$0.00	$0.00	Disclosure SEC source: 0001127602-22-024923 · form4.xml · derivative · entry 4 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,876 Underlying: Common Stock · 9,170 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units vest in full on April 15, 2024. F6 · derivative.expiration_date: The Restricted Stock Units vest in full on April 15, 2024. Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:04 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	GrantPerformance Share Unit · Derivative	9,170	$0.00	$0.00	Disclosure SEC source: 0001127602-22-024923 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,170 Underlying: Common Stock · 9,170 shares Expires 2024-05-10 F3 · security: Performance Share Unit granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F4 · derivative.exercise_price: Each Performance Share Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F5 · derivative.exercise_date: The Performance Share Units vest in full upon the filing of the Company's Quarterly Report on Form 10-Q for the first quarter of 2024, subject to both continued service and a performance condition related to the Issuer's contemplated spin-off transaction. F5 · derivative.expiration_date: The Performance Share Units vest in full upon the filing of the Company's Quarterly Report on Form 10-Q for the first quarter of 2024, subject to both continued service and a performance condition related to the Issuer's contemplated spin-off transaction. Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:04 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	5,348	$222.56	$1,190,250.88	Disclosure SEC source: 0001127602-22-024923 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,842 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:04 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	12,032	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-22-024923 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document
September 26, 2022 Filed Sep 28, 2022 13:12 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	2,830	$211.86	$599,573.42	Disclosure SEC source: 0001127602-22-023065 · form4.xml · nonDerivative · entry 4 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,158 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · price: The price of $211.8634 per share represents a weighted average of sales prices ranging from $211.66 to $212.13 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
September 26, 2022 Filed Sep 28, 2022 13:12 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	11,699	$211.13	$2,470,063.69	Disclosure SEC source: 0001127602-22-023065 · form4.xml · nonDerivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,988 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price of $211.1346 per share represents a weighted average of sales prices ranging from $210.66 to $211.65 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
September 26, 2022 Filed Sep 28, 2022 13:12 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	4,844	$210.21	$1,018,241.74	Disclosure SEC source: 0001127602-22-023065 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,687 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price of $210.2068 per share represents a weighted average of sales prices ranging from $209.66 to $210.64 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
September 26, 2022 Filed Sep 28, 2022 13:12 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	5,627	$209.29	$1,177,697.34	Disclosure SEC source: 0001127602-22-023065 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,531 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price of $209.2940 per share represents a weighted average of sales prices ranging from $208.65 to $209.62 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
August 03, 2022 Filed Aug 5, 2022 13:52 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionNon-qualified Stock Options · Derivative	11,600	$0.00 Strike: $146.59	$0.00	Disclosure SEC source: 0001127602-22-020514 · form4.xml · derivative · entry 9 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,600 shares Expires 2029-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F5 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column. Read SEC document
August 03, 2022 Filed Aug 5, 2022 13:52 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionNon-qualified Stock Options · Derivative	9,100	$0.00 Strike: $168.49	$0.00	Disclosure SEC source: 0001127602-22-020514 · form4.xml · derivative · entry 8 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,100 shares Expires 2028-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F5 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column. Read SEC document
August 03, 2022 Filed Aug 5, 2022 13:52 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionNon-qualified Stock Options · Derivative	11,400	$0.00 Strike: $130.60	$0.00	Disclosure SEC source: 0001127602-22-020514 · form4.xml · derivative · entry 7 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,400 shares Expires 2027-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F5 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column. Read SEC document
August 03, 2022 Filed Aug 5, 2022 13:52 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	1,500	$254.88	$382,318.50	Disclosure SEC source: 0001127602-22-020514 · form4.xml · nonDerivative · entry 6 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,158 F3 · price: The price of $254.879 per share represents a weighted average of sales prices ranging from $254.75 to $255.02 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
August 03, 2022 Filed Aug 5, 2022 13:52 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	19,338	$254.26	$4,916,860.54	Disclosure SEC source: 0001127602-22-020514 · form4.xml · nonDerivative · entry 5 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,658 F2 · price: The price of $254.259 per share represents a weighted average of sales prices ranging from $253.71 to $254.71 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
August 03, 2022 Filed Aug 5, 2022 13:52 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	11,262	$253.27	$2,852,270.43	Disclosure SEC source: 0001127602-22-020514 · form4.xml · nonDerivative · entry 4 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,996 F1 · price: The price of $253.265 per share represents a weighted average of sales prices ranging from $252.71 to $253.70 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
August 03, 2022 Filed Aug 5, 2022 13:52 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	11,600	$146.59	$1,700,444.00	Disclosure SEC source: 0001127602-22-020514 · form4.xml · nonDerivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 03, 2022 Filed Aug 5, 2022 13:52 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	9,100	$168.49	$1,533,259.00	Disclosure SEC source: 0001127602-22-020514 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 03, 2022 Filed Aug 5, 2022 13:52 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	11,400	$130.60	$1,488,840.00	Disclosure SEC source: 0001127602-22-020514 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 02, 2022 Filed May 3, 2022 16:30 UTC	US Ecology, Inc. ECOL · Entity 127674	Disposition to issuerCommon Stock	9,000	$48.00	$432,000.00	Disclosure SEC source: 0001437749-22-010686 · rdgdoc.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. ("Parent") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest ("Merger Consideration"). F1 · shares: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. ("Parent") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest ("Merger Consideration"). Read SEC document
March 28, 2022 Filed Mar 29, 2022 16:05 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	6,286	$276.42	$1,737,576.12	Disclosure SEC source: 0001127602-22-010504 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,158 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
March 27, 2022 Filed Mar 29, 2022 16:05 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	GrantCommon Stock	14,144	$0.00	$0.00	Disclosure SEC source: 0001127602-22-010504 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,444 F1 · kind: Shares acquired on March 27, 2022, pursuant to a performance award granted on February 12, 2019, relating to performance during the three-year period ended December 31, 2021. Read SEC document
February 14, 2022 Filed Feb 15, 2022 21:43 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	277	$272.68	$75,532.36	Disclosure SEC source: 0001127602-22-005028 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,300 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
February 12, 2022 Filed Feb 15, 2022 21:43 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionRestricted Stock Unit · Derivative	940	$0.00	$0.00	Disclosure SEC source: 0001127602-22-005028 · form4.xml · derivative · entry 5 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,706 Underlying: Common Stock · 940 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 12, 2020 and are now fully vested. F7 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 12, 2020 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
February 12, 2022 Filed Feb 15, 2022 21:43 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	940	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-22-005028 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,577 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:43 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	GrantNon-qualified Stock Options · Derivative	7,700	$0.00 Strike: $276.26	$0.00	Disclosure SEC source: 0001127602-22-005028 · form4.xml · derivative · entry 4 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,700 Underlying: Common Stock · 7,700 shares Expires 2032-02-10 F5 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F6 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.